We also showed for the first time how a long-term administration of the antidepressants fluoxetine and vortioxetine, able to rescue the TGF-β1 pathway, can also contribute to prevent amyloid-induced depression and cognitive decline by counteracting Aβ-induced oxidative stress. The gene discussed is TGFB1; the disease is Mental deterioration.